Multiple sclerosis [MS] is often characterized by relapsing episodes of neurologic impairment followed by remissions. In about a third of MS patients this disease evolves into a progressive course, termed secondary progressive MS (1). In a minority of patients progressive neurologic deterioration without remission occurs from the onset of disease, and this is called primary progressive MS. The pathophysiologic and genetic causes underlying primary versus secondary progressive MS remain unclear (2, 3, 4) .
Osteopontin, also called early T cell activation gene-1, (5, 6) , has pleiotropic functions (7, 8, 9) , including roles in inflammation and in immunity to infectious diseases (8) . OPN costimulates T cell proliferation (8) , and is classified as a Th1 cytokine, due to its ability to enhance IFN-gamma and IL-12 production, and to diminish IL-10 (10). We investigated a role for OPN in MS and an experimental model for MS, experimental autoimmune encephalomyelitis [EAE] .
Initially we set out to identify gene transcripts involved in the inflammatory response that might be increased in the central nervous system during active EAE, and which returned to normal when EAE was successfully treated after the onset of paralysis. Customized oligonucleotide microarrays were produced to monitor transcription of genes involved in inflammatory responses (11) (12) (13) (14) . These initial microarray experiments showed that osteopontin transcripts were elevated in the brains of rats with EAE, and not in brains of rats protected from EAE. Details of these experiments are available on the internet (14) .
In parallel, we performed high throughput sequencing of expressed sequence tags [EST], utilizing non-normalized cDNA brain libraries (15, 16, 17) , generated from MS brain lesions and control brain (18) . Using this protocol the mRNA populations present in the brain specimens are accurately represented, enabling the quantitative estimation of transcripts and comparisons between specimens (18) ( Table 1 and web Table 1 tissue type, and constructed with an identical protocol, revealed that OPN transcripts were frequently detected, and exclusive to the MS mRNA population, but not that of control brain (Table 1) .
We sequenced over 11,000 clones from MS libraries 1 and 2, and control libraries, respectively (Web Fig. 1 [ref. 14]), and focused analysis on genes present in both MS libraries, but absent in the control library (18). This yielded 423 genes, including 26 novel genes. From those, 54 genes showed a mean fold change of 2.5 or higher in MS libraries 1 and 2 [ Table 1 ].
Transcripts for alpha B-crystallin, an inducible heat shock protein, localized in the myelin sheath, and known to be targeted by T cells in MS, were the most abundant transcripts unique to MS plaques (19) [ Table 1 ].
The next five most abundant transcripts, included those for prostaglandin D synthase, prostatic binding protein, ribosomal protein L17, and OPN.
Next we analyzed all genes present in each of the three cDNA libraries, and found 330 (7 novel) genes. Based on the clone count of each sequenced gene, a Expression of HSP70-1, which is involved in myelin folding (20) was significantly elevated.
Although not differentially expressed, GFAP was among the three most abundant species in all the libraries, consistent with a prominent glial (or astrocytic) response in the MS brains. Six genes belonging to the KIAA group of large-size cloned mRNAs, showed differential expression. The decreased transcription of synaptobrevin might be of interest given that it belongs to a family of small integral membrane proteins specific for synaptic vesicles in neurons.
Recent evidence indicates that axonal loss is one of the major components of pathology in MS (21, 22).
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Given the known inflammatory role for OPN, we examined the cellular expression pattern of this protein in human MS plaques and in control tissue, by immunohistochemistry. To identify cells expressing OPN in situ we used a polyclonal antibody, generated in mouse against recombinant GST-OPN, to stain postmortem MS and control tissue samples (23) (Fig. 1A and   B ). Within active MS plaques OPN was found on microvascular endothelial cells and macrophages (Fig. 1A) , and in white matter adjacent to plaques. Reactive astrocytes and microglia also expressed OPN (Fig. 1B) .
The role of OPN in inflammatory demyelinating disease was next examined using two models of EAE (1 Fig. 1C-F) . OPN was expressed broadly in microglia during both relapse and remission from disease, and this expression was focused near perivascular inflammatory lesions. In addition to OPN expression on glia, expression in neurons was detectable during acute disease, and relapse, but not during remission. To confirm the expression of OPN in an acute form of EAE, a rapid, monophasic demyelinating disease was induced in Lewis rats (12) , and OPN immunostaining was performed on brains ( Fig. 1G ) (29).
OPN expression in microglia and neurons was predominant in the sick rats, and was focused close to the acute lesions, as was observed in the relapsing/remitting mouse model of EAE.
Staining of OPN in bone with the same antibody MPIIIB10 1 served as a positive control (Fig.   1H ). These results strongly implicated OPN in acute, as well as in relapsing forms of EAE, and suggested that the degree of expression of OPN in lesions correlated with the severity of disease.
The potential role of OPN in demyelinating disease was next tested using OPN deficient mice [ Fig. 2 To examine whether different immune responses were involved in OPN-/-and OPN+/+ animals, we tested the profile of cytokine expression in these mice. Since EAE is a T cell mediated disease, we first analyzed the T cell proliferative response to the auto-antigen MOG 35-55 in the OPN-/-mice. T cells in OPN-/-mice showed a reduced proliferative response to MOG 35-55, compared with OPN+/+ T cells (Fig. 3A) . In addition, IL-10 production was increased in T cells reactive to MOG 35-55 in OPN-/-mice that had developed EAE, compared with T cells in OPN+/+ mice ( Fig. 3B) . At the same time, IFN-gamma and IL-12 production was diminished in the cultures of spleen cells stimulated with MOG ( Fig. 3C-D) .
Since IFN-γ and IL-12 are important pro-inflammatory cytokines in MS (1, 33), the finding that in OPN-/-mice there is reduced production of these cytokines, is consistent with the hypothesis that OPN may play a critical role in the modulation of Th1 immune responses in MS and EAE. Further, IL-10 has been associated with remission from EAE (34). In this context, the enhancement of myelin specific IL-10 production in OPN-/-mice, may account for the tendency of these mice to go into remission. Sustained expression of IL-10 may thus be an important factor in the reversal of relapsing MS, and its absence may allow the development of secondary progressive MS. 
(C) OPN was broadly expressed in CNS microglia, especially near inflammatory lesions, but not in adjacent peripheral nerves (arrow). (D)
Expression in neurons (arrows) was detectable during the acute phase (N=4) and relapse (N=2), but not during remission (N=1) or in mice with inflammatory lesions which never developed paralysis (N=2). (E) OPN expression in astrocytes (arrows) and choroid plexus cells (F) was also more frequent and more pronounced in immunized mice (100%) than in controls (25%).
G. Acute EAE in rat. EAE was induced in 19
Lewis rats (The Jackson Laboratory) as described in (13) Only genes corresponding to transcripts with an average fold difference of ≥2 are listed. The first section of the table lists genes whose expression was statistically significant in both MS libraries when compared to the CTRL library (Fisher's exact test, p<0.05 ). The second section contains genes with significant difference in expression in only one of the MS libraries and the CTRL. The last section includes genes with non-significant differences but AFD ≥ ±3.00. N/A, mapping position is not known. *, genomic regions that reached nominal criteria of linkage in genome-wide screenings. and total RNA prepared according to the recommended protocol. mRNA was purified by two rounds of selection using oligo(dT) resin (Oligotex, Qiagen). 2 µg of mRNA was used to prepare double stranded cDNA (Superscript, Gibco BRL). The primer for cDNA synthesis contained a T7 RNA polymerase promoter site. 1 µg of cDNA was used for an in-vitro 
Further details of the initial experiment with custom microarrays (11):
Custom microarrays were designed that allow large scale profiling of mRNA for 517 components of the inflammatory response, including cytokines, chemokines, various adhesion molecules, and matrix metalloproteases. Profiles of mRNA transcripts from the spinal cord of six Lewis rats with EAE were analyzed. Rats were immunized with 400µg of guinea pig spinal cord homogenate [GPSCH] and monitored for EAE as previously described (12) . mRNA was isolated from the brain and spinal cord of three rats with hind limb paralysis (mean EAE score 2.7, indicating severe paraplegia), 15 days after immunization with GPSCH, and from three rats treated with a metalloprotease inhibitor after the initiation of EAE. It is established that matrix metalloprotease inhibitors can reverse EAE (13) , and rats treated with the metalloprotease inhibitor [RS110379] displayed no clinical disease (mean EAE score 0.2). Spinal cord from two other normal rats served as controls.
OPN transcripts were increased 3.4 fold in the spinal cord of rats with EAE and paralysis, compared to controls without EAE (average difference change for intensity of OPN 26 26 transcripts was 16609 fluorescent units in untreated rats with EAE versus an average difference change for intensity in OPN transcripts of 4846 in rats without EAE) (14) . After treatment with RS110379, levels of OPN mRNA were no different than control rats without EAE. Thus, there was a 1.1 fold change between the intensity of OPN transcripts in EAE rats treated with MMP inhibitor versus rats without EAE (the average difference of the change in intensity of OPN transcripts on the custom microarrays was 5176 units in rats treated with RS110379 versus an average difference intensity of 4846 units in rats without EAE) (14) .
